Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Also known as: Blastic Plasmacytoid Dendritic Cell Neoplasm

DrugDrug NameDrug Description
DB14731TagraxofuspA CD123-directed cytotoxin used to treat plasmacytoid dendritic cell neoplasm.
DrugDrug NamePhaseStatusCount
DB00531Cyclophosphamide1Recruiting1
DB01073Fludarabine1Recruiting2
DB11581Venetoclax1Recruiting1
DB00531Cyclophosphamide1 / 2Not Yet Recruiting1
DB01262Decitabine1 / 2Not Yet Recruiting1
DB01073Fludarabine1 / 2Not Yet Recruiting1
DB14731Tagraxofusp1 / 2Active Not Recruiting1
DB14731Tagraxofusp1 / 2Completed1
DB09312Antilymphocyte immunoglobulin (horse)2Not Yet Recruiting1
DB00098Antithymocyte immunoglobulin (rabbit)2Not Yet Recruiting1
DB01008Busulfan2Recruiting1
DB00531Cyclophosphamide2Not Yet Recruiting1
DB00531Cyclophosphamide2Recruiting2
DB01073Fludarabine2Not Yet Recruiting1
DB01073Fludarabine2Recruiting2
DB00563Methotrexate2Not Yet Recruiting1
DB00563Methotrexate2Recruiting2
DB00688Mycophenolate mofetil2Recruiting1
DB06132Nivolumab2Active Not Recruiting1
DB09035Nivolumab2Active Not Recruiting1
DB00864Tacrolimus2Not Yet Recruiting1
DB00864Tacrolimus2Recruiting2
DB04572Thiotepa2Not Yet Recruiting1
DB04572Thiotepa2Recruiting2
DB03754Tromethamine2Recruiting1
DB00091CyclosporineNot AvailableActive Not Recruiting1
DB01073FludarabineNot AvailableActive Not Recruiting1
DB00688Mycophenolate mofetilNot AvailableActive Not Recruiting1